27777972|t|Improving vascular maturation using noncoding RNAs increases antitumor effect of chemotherapy
27777972|a|Current antiangiogenesis therapy relies on inhibiting newly developed immature tumor blood vessels and starving tumor cells. This strategy has shown transient and modest efficacy. Here, we report a better approach to target cancer -associated endothelial cells (ECs), reverse permeability and leakiness of tumor blood vessels, and improve delivery of chemotherapeutic agents to the tumor. First, we identified deregulated microRNAs (miRs) from patient -derived cancer -associated ECs. Silencing these miRs led to decreased vascular permeability and increased maturation of blood vessels. Next, we screened a thioaptamer (TA) library to identify TAs selective for tumor -associated ECs. An annexin A2 - targeted TA was identified and used for delivery of miR106b-5p and miR30c-5p inhibitors, resulting in vascular maturation and antitumor effects without inducing hypoxia. These findings could have implications for improving vascular - targeted therapy.
27777972	10	29	vascular maturation	T038	UMLS:C1621275
27777972	36	50	noncoding RNAs	T103	UMLS:C0887909
27777972	81	93	chemotherapy	T058	UMLS:C3665472
27777972	102	126	antiangiogenesis therapy	T058	UMLS:C0281318
27777972	173	192	tumor blood vessels	T038	UMLS:C0027668
27777972	206	217	tumor cells	T017	UMLS:C0597032
27777972	318	324	cancer	T038	UMLS:C0006826
27777972	337	354	endothelial cells	T017	UMLS:C0225336
27777972	356	359	ECs	T017	UMLS:C0225336
27777972	400	419	tumor blood vessels	T038	UMLS:C0027668
27777972	445	468	chemotherapeutic agents	T103	UMLS:C0729502
27777972	476	481	tumor	T038	UMLS:C0027651
27777972	516	525	microRNAs	T103	UMLS:C1101610
27777972	527	531	miRs	T103	UMLS:C1101610
27777972	555	561	cancer	T038	UMLS:C0006826
27777972	574	577	ECs	T017	UMLS:C0225336
27777972	579	588	Silencing	T038	UMLS:C0598496
27777972	595	599	miRs	T103	UMLS:C1101610
27777972	617	638	vascular permeability	T038	UMLS:C0162337
27777972	653	680	maturation of blood vessels	T038	UMLS:C1621275
27777972	691	699	screened	T058	UMLS:C1710032
27777972	702	713	thioaptamer	T103	UMLS:C0599013
27777972	715	717	TA	T103	UMLS:C0599013
27777972	719	726	library	T017	UMLS:C0017272
27777972	739	742	TAs	T103	UMLS:C0599013
27777972	757	762	tumor	T038	UMLS:C0027651
27777972	775	778	ECs	T017	UMLS:C0225336
27777972	783	793	annexin A2	T103	UMLS:C0103404
27777972	805	807	TA	T103	UMLS:C0599013
27777972	848	858	miR106b-5p	T103	UMLS:C1101610
27777972	863	872	miR30c-5p	T103	UMLS:C1101610
27777972	898	906	vascular	T017	UMLS:C0005847
27777972	907	917	maturation	T038	UMLS:C0678723
27777972	957	964	hypoxia	T038	UMLS:C0242184
27777972	972	980	findings	T033	UMLS:C0243095
27777972	1019	1027	vascular	T017	UMLS:C0005847